Skip to main content

FDA recall, , Moderate risk

NIPRO Conductivity Standard Solutions

Conductivity Standard Solution has a defect that can cause incorrect conductivity values for dialysate.

What happened

NIPRO Technical Services, Inc. of Mesa, Arizona, recalled Conductivity Standard Solution due to a defect that can cause incorrect conductivity values for dialysate. The recall began December 12, 2025, and was added to the FDA's Enforcement Report on January 27, 2026.

The recalled solution was distributed nationwide in states including Alabama, Arkansas, Arizona, California, Delaware, Florida, Georgia, Illinois, Indiana, Kansas, Michigan, Missouri, North Carolina, North Dakota, New Jersey, Nevada, New York, Ohio, Oklahoma, Oregon, Pennsylvania, South Carolina, Tennessee, Texas, Utah, Virginia, and Washington. The solution is a secondary standard used for the calibration of conductivity cells together with conductivity meters.

What to do

We don't have product-specific instructions for this recall. FDA's general advice for medical device recalls:

  1. A device recall doesn't always mean you must stop using it: it may need to be checked, adjusted or fixed.
  2. Talk to your health care provider before you stop using it.

Is yours affected?

Affected if its model number and UDI-DI are listed under that product.

A UDI-DI is the device identifier printed with the barcode on the device label.

  1. Conductivity Standard Solution

    Model number
    • 10001
    • 10011
    • 10021
    • 10032
    • 10040
    • 10040c
    • 10041
    UDI-DI
    • 14250616
    • 50250624
    • 50250522

Recall details

Company began the recall
Company
NIPRO Technical Services, Inc.Mesa, Arizona
Risk

Moderate risk

Using it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.

FDA Class II recall · How risk is rated

Event ID
98030
Recall number
Z-1185-2026
Quantity recalled
499 units

Timeline

FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.

  1. Company began the recall

  2. Added to FDA's Enforcement Report · Classified by FDA

  3. In FDA's weekly enforcement report

  4. Listed on Recall Canary

Summary by Recall Canary, written with AI · summary updated Oct 23, 2026 · primary source: U.S. Food and Drug Administration (opens in a new tab)